ORKAMBI (lumacaftor/ivacaftor) tablets is used for the treatment of patients with cystic fibrosis.

ORKAMBI is a combination of lumacaftor and ivacaftor, a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, indicated for the treatment of cystic fibrosis (CF) in patients age 2 years and older who are homozygous for the F508del mutation in the CFTR gene. If the patient’s genotype is unknown, an FDA-cleared CF mutation test should be used to detect the presence of the F508del mutation on both alleles of the CFTR gene.

ORKAMBI (lumacaftor/ivacaftor) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ORKAMBI (lumacaftor/ivacaftor) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ORKAMBI (lumacaftor/ivacaftor) tablets medicine cost price in India.

The order for ORKAMBI (lumacaftor/ivacaftor) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Lumacaftor/ivacaftor, sold under the brand name Orkambi among others, is a combination of lumacaftor and ivacaftor used to treat people with cystic fibrosis who have two copies of the F508del mutation. It is unclear if it is useful in cystic fibrosis due to other causes.

ORKAMBI (lumacaftor/ivacaftor) tablets, for oral use Initial U.S. Approval: 2015

Generic Name: lumacaftor/ivacaftor

Tablets: lumacaftor 100 mg and ivacaftor 125 mg; lumacaftor 200 mg and ivacaftor 125 mg.
• Oral granules: Unit-dose packets of lumacaftor 100 mg and ivacaftor 125 mg; lumacaftor 150 mg and ivacaftor 188 mg.

ORKAMBI (lumacaftor/ivacaftor) tablets Price In Delhi India.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient, providing solutions on how to get access of anti cancer medicines which is not available in India.


Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support


ORKAMBI (lumacaftor/ivacaftor) tablets suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ORKAMBI (lumacaftor/ivacaftor) tablets on prescription and Import License in Patient's Name only.

For overseas patients, ORKAMBI (lumacaftor/ivacaftor) tablets can be made available in Send your enquiry to find ORKAMBI (lumacaftor/ivacaftor) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for ORKAMBI (lumacaftor/ivacaftor) tablets.

For ORKAMBI (lumacaftor/ivacaftor) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Orkambi Approved by FDA as First CF Medicine for Children Ages 2-5 For More Details

FDA-approved, three-drug combination treatment for cystic fibrosis For More Details